Sector: Life Sciences
64x Bio is engineering cell lines to address critical challenges in gene therapy manufacturing.
908 Devices makes handheld and desktop mass spectrometry devices to enable lab analysis wherever and whenever it’s needed.
Ansa Biotechnologies is building a next-generation, enzyme-based approach to DNA synthesis that accelerates synthetic biology research.
Culture helps scientists accelerate bioprocess development with its high-throughput bioreactor cloud lab.
Emulate is pioneering organ-on-a-chip technology and enabling laboratory simulation of the human response to medicines, chemicals, and foods.
Encodia enables researchers to probe the immense complexities of the proteome routinely at a scale and resolution that was previously unattainable.
EnPlusOne is manufacturing the RNA medicines of the future.
General Inception partners with inventors to ignite innovation and support their journey from inception to market.
Intabio provides drug producers a rapid system to confirm their batches of drugs are meeting high-quality standards.
Isolation Bio enables access to the living microbiome at unprecedented scale, enabling scientists to uncover deeper insights.
Isolere Bio is simplifying and streamlining the purification of biotherapeutics to improve global access to important drugs.
Kytopen enables non-viral manufacturing of cell therapies in a scalable process that preserves and minimally disrupts each cell.
NanoView characterizes exosomes – which are how cells communicate with each other – direct from sample and without purification.
Ori Biotech automates and scales cell and gene therapy manufacturing to reduce costs, meet rapidly growing demand, and enable patient access to lifesaving treatments.
PhenomeX is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology that will advance human health.
Refeyn is a research tools company whose novel technology can find and characterize single molecules in only one minute, rapidly accelerating research for new drugs.
Slingshot Biosciences develops synthetic cells for a range of applications in diagnostics and therapeutics.
Telesis bridges the digital and biological words to create specific genetic components that researchers need to better understand diseases and develop therapies.
Ultivue’s immunohistochemistry platform is used in cancer research by leading biopharmaceutical companies to provide sensitive and comprehensive biomarker information that can advance promising cancer drugs to and through clinical trials.
Vizgen’s multiplexed FISH technology, “MERFISH” allows researchers to profile gene expression with sub-cellular spatial resolution.